Akanda Targets 10% of German Medical Cannabis Market with its Premium Flower Cultivation Operations in Portugal

Author's Avatar
Nov 16, 2022

Medical cannabis cultivation company Akanda Corp. ("Akanda" or the "Company") (NASDAQ: AKAN) (Frankfurt: Y23) is affirming a shift in strategy to become a significant player as a premium EU GMP cultivator in Europe, targeting 10% market share in the German medical cannabis flower market in the near term. Akanda+also+has+a+cultivation+and+dispensary+licensing+deal+with+Cookies%26reg%3B+in+Portugal. These steps put Akanda on firm footing to serve the future regulated adult-use markets in Europe once established.